Skip to main content
Equibles
DHR logo

DHR · Danaher Corp /De/ · Metrics

Track DHR — free

Use DHR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$205.23 -2.43 (-1.17%) At close · Sep 8
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$145.98B
Shares
702.99M

DHR metrics

97 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$205.23
Market cap
$145.98B

Price action

20 metrics
Price change (1W)
-3.9%
Price change (30D)
-0.8%
Price change (3M)
+12.7%
Price change (6M)
+6.2%
Price change (YTD)
-9.3%
Price change (1Y)
+4.3%
Trailing year
Price change (5Y)
—
52-week high
$242.05
52-week low
$161.91
Change from 52-week high
-14.2%
Change from 52-week low
+28.3%
Annualized volatility
31.4%
Annualized volatility (3M)
38.5%
Beta
0.4
RSI (14D)
50.5
Price vs SMA 50
+3.0%
Price vs SMA 200
+2.4%
Avg volume (3M)
4.62M
Relative volume
0.6
Average dollar volume
$900.12M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
702.99M

Valuation

12 metrics
P / E (TTM)
36.8
Trailing earnings · reciprocal yield 2.7%
PEG ratio
0.6
EV / revenue
6.7×
reciprocal yield 14.9%
EV / EBITDA
—
EV / EBIT
32.8×
reciprocal yield 3.0%
P / sales
5.8×
reciprocal yield 17.2%
P / book
2.8
reciprocal yield 36.0%
FCF yield
3.7%
TTM · current market cap
Buyback yield
2.0%
P / FCF
26.7
reciprocal yield 3.7%
P / operating cash flow
22.0
reciprocal yield 4.5%
Earnings yield
2.7%

Historical valuation

8 metrics
P / E historical average (3Y)
39.2×
reciprocal yield 2.6%
P / E historical average (5Y)
36.7×
reciprocal yield 2.7%
EV / revenue historical average (3Y)
7.0×
reciprocal yield 14.3%
EV / revenue historical average (5Y)
7.1×
reciprocal yield 14.2%
EV / EBIT historical average (3Y)
34.0×
reciprocal yield 2.9%
EV / EBIT historical average (5Y)
31.9×
reciprocal yield 3.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.7%
Trailing 12 months
Payout ratio
24.1%
Shareholder yield
2.6%
Dividend / share (TTM)
$1.44
Dividend growth YoY
+22.0%
Dividend growth streak
5
Last ex-dividend
2026-06-26

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-21

Profitability

9 metrics
Gross margin
58.5%
Operating margin
20.4%
Trailing 12 months
Net margin
15.9%
Gross profit (TTM)
$14.69B
Operating profit (TTM)
$5.13B
Net income (TTM)
$4.00B
Trailing 12 months
Diluted EPS (TTM)
$5.64
FCF margin
21.8%
Effective tax rate
16.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$18.52

Growth

11 metrics
Revenue growth YoY
+5.5%
Year over year
Net income growth YoY
+56.8%
Revenue (TTM)
$25.11B
Trailing 12 months
EPS growth YoY
+59.7%
Shares change YoY
-1.6%
Year over year · fewer shares
Revenue CAGR (3Y)
-2.7%
Revenue CAGR (5Y)
+2.0%
EPS CAGR (3Y)
-19.4%
EPS CAGR (5Y)
+3.1%
FCF CAGR (3Y)
-10.8%
FCF CAGR (5Y)
-0.6%

Quality

14 metrics
Return on equity
7.6%
Return on assets
4.3%
Debt / equity
0.5
Current ratio
1.7
EBITDA (TTM)
—
Free cash flow (TTM)
$5.47B
Quick ratio
1.2
Interest coverage
17.6
Net debt / EBITDA
—
Return on invested capital
5.7%
Trailing 12 months
Net cash
−$22.21B
Latest balance sheet
Cash & equivalents
$4.35B
Total assets
$92.37B
Total debt
$26.56B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$6.63B
Capital expenditures (TTM)
$1.17B
R&D (TTM)
$1.61B
SG&A (TTM)
$7.95B
Stock compensation (TTM)
$297.00M
R&D / revenue
6.4%
Stock compensation / revenue
1.2%

Ownership (13F)

3 metrics
13F filers
2,117
13F filer change QoQ
-70
Institutional ownership
83.0%

Short interest

3 metrics
Short interest
1.2%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
39 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$12.74M
Insider-sentiment score
35 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 313616 CUSIP 235851102 13F (30d) 925 filings 882 filers Visit website Investor relations